Survey of use of anticoagulation in patients with atrial fibrillation.
作者信息
Bath P M, Prasad A, Brown M M, MacGregor G A
机构信息
Blood Pressure Unit, St George's Hospital Medical School, London.
出版信息
BMJ. 1993 Oct 23;307(6911):1045. doi: 10.1136/bmj.307.6911.1045.
Abstract
摘要
相似文献
1
Survey of use of anticoagulation in patients with atrial fibrillation.心房颤动患者抗凝治疗使用情况调查。
BMJ. 1993 Oct 23;307(6911):1045. doi: 10.1136/bmj.307.6911.1045.
2
Underuse of anticoagulation in older patients with chronic atrial fibrillation: malpractice or accuracy?老年慢性心房颤动患者抗凝治疗的使用不足：是医疗失误还是合理选择？
J Am Geriatr Soc. 1999 Aug;47(8):1034-5. doi: 10.1111/j.1532-5415.1999.tb01303.x.
3
4
Warfarin, aspirin, and atrial fibrillation.华法林、阿司匹林与心房颤动。
Harv Heart Lett. 1998 Aug;8(12):4-6.
5
Anticoagulants for atrial fibrillation.用于心房颤动的抗凝剂。
Med J Aust. 1992 Jul 20;157(2):77-8.
6
Temporal trends in the use of anticoagulants among older adults with atrial fibrillation.老年房颤患者抗凝药物使用的时间趋势。
Arch Intern Med. 1999 Jul 26;159(14):1574-8. doi: 10.1001/archinte.159.14.1574.
7
ABC of atrial fibrillation. Antithrombotic treatment for atrial fibrillation.心房颤动基础知识。心房颤动的抗栓治疗。
BMJ. 1996 Jan 6;312(7022):45-9. doi: 10.1136/bmj.312.7022.45.
8
Recent national patterns of warfarin use in atrial fibrillation.近期全国范围内心房颤动患者使用华法林的情况
Circulation. 1998 Apr 7;97(13):1231-3. doi: 10.1161/01.cir.97.13.1231.
9
Warfarin use among patients with atrial fibrillation.心房颤动患者使用华法林的情况。
Stroke. 1997 Dec;28(12):2382-9. doi: 10.1161/01.str.28.12.2382.
10
Warfarin versus aspirin in the elderly in primary prophylaxis for atrial fibrillation.华法林与阿司匹林用于老年患者心房颤动一级预防的比较
Age Ageing. 2007 Mar;36(2):117-9. doi: 10.1093/ageing/afl181. Epub 2007 Jan 25.
引用本文的文献
1
Potential missed opportunities to prevent ischaemic stroke: prospective multicentre cohort study of atrial fibrillation-associated ischaemic stroke and TIA.潜在的缺血性脑卒中预防机会错失：前瞻性多中心队列研究房颤相关性缺血性脑卒中及 TIA。
BMJ Open. 2019 Jul 24;9(7):e028387. doi: 10.1136/bmjopen-2018-028387.
2
Could geriatric characteristics explain the under-prescription of anticoagulation therapy for older patients admitted with atrial fibrillation? A retrospective observational study.老年特征能否解释老年心房颤动患者入院时抗凝治疗不足？一项回顾性观察研究。
Drugs Aging. 2010 Oct 1;27(10):807-13. doi: 10.2165/11537900-000000000-00000.
3
Influence of decision aids on patient preferences for anticoagulant therapy: a randomized trial.决策辅助工具对抗凝治疗患者偏好的影响：一项随机试验。
CMAJ. 2007 May 22;176(11):1583-7. doi: 10.1503/cmaj.060837.
4
Mortality and rate of stroke or embolism in atrial fibrillation during long-term follow-up in the embolism in left atrial thrombi (ELAT) study.左心房血栓栓塞（ELAT）研究中长期随访期间心房颤动患者的死亡率及中风或栓塞发生率
Clin Cardiol. 2004 Jan;27(1):40-6. doi: 10.1002/clc.4960270111.
5
Problems, interventions and complications in long-term oral anticoagulation therapy.长期口服抗凝治疗中的问题、干预措施及并发症
J Thromb Thrombolysis. 2002 Aug;14(1):65-72. doi: 10.1023/a:1022070406307.
6
Anticoagulants for atrial fibrillation: why is the treatment rate so low?用于心房颤动的抗凝剂：为何治疗率如此之低？
Clin Cardiol. 2002 Oct;25(10):447-54. doi: 10.1002/clc.4960251003.
7
Is warfarin really underused in patients with atrial fibrillation?华法林在房颤患者中真的未得到充分使用吗？
J Gen Intern Med. 2001 Nov;16(11):743-9. doi: 10.1111/j.1525-1497.2001.10432.x.
8
Stroke and atrial fibrillation: is stroke prevention treatment appropriate beforehand? SAFE I Study Investigators.中风与心房颤动：预先进行中风预防治疗是否合适？SAFE I研究调查人员
Heart. 1999 Nov;82(5):563-9. doi: 10.1136/hrt.82.5.563.
9
A community survey of patients with atrial fibrillation: associated disabilities and treatment preferences.一项针对房颤患者的社区调查：相关残疾情况及治疗偏好
Br J Gen Pract. 1998 Nov;48(436):1775-8.
10
Randomised trial of educational visits to enhance use of systematic reviews in 25 obstetric units.在25个产科单位进行的关于教育访问以促进系统评价使用情况的随机试验。
BMJ. 1998 Oct 17;317(7165):1041-6. doi: 10.1136/bmj.317.7165.1041.
本文引用的文献
1
Antithrombotic treatment and atrial fibrillation.抗栓治疗与心房颤动
BMJ. 1993 Jan 16;306(6871):207. doi: 10.1136/bmj.306.6871.207-b.
2
Warfarin in chronic atrial fibrillation.华法林用于慢性心房颤动
Lancet. 1993 May 29;341(8857):1376-7. doi: 10.1016/0140-6736(93)90945-d.
3
Cost effectiveness of primary stroke prevention in atrial fibrillation: Swedish national perspective.心房颤动一级预防的成本效益：瑞典国家视角
BMJ. 1992 Dec 12;305(6867):1457-60. doi: 10.1136/bmj.305.6867.1457.
4
Antithrombotic treatment and atrial fibrillation.抗栓治疗与心房颤动
BMJ. 1992 Dec 12;305(6867):1445-6. doi: 10.1136/bmj.305.6867.1445.
Zotero 插件